Company intelligence / Profile preview

OrbusNeich

Ownership: Private
Employees: ~500
Development stage: Commercial

Overview

OrbusNeich is a global leader in the design, development, manufacturing, and marketing of interventional medical devices for vascular diseases. Its flagship product is the COMBO Dual Therapy Stent featuring endothelial progenitor cell capture technology. The company’s products are CE-marked and FDA/NMPA approved for various indications and are used worldwide in both coronary and peripheral interventions. Clinical trials have demonstrated low event rates with their dual therapy stent platform

Therapeutic areas: CardiovascularNeurology
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Orbus Medical Technologies Inc.

Beyond the preview

Go deeper on OrbusNeich.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OrbusNeich.

Explore the full profile